Komori
Qol Holdings (3034) · InitiativeAdvanced

Directors’ Compensation Policy of the Nomination and Compensation Committee

First written in FY2021. 3 of 4 entries say "Advanced", first in FY2022. Latest entry: FY2026.

4entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2021AdvancedFY2022 – FY20262021: 120212022: 120222023: 020232024: 120242025: 020252026: 12026
Same theme, other companies
Executive Compensation Policy and Design Combining Fixed and Share-Based CompensationA theme 89 companies write about · 12 as a headwind · 56 as a tailwind

The whole theme swung hardest in 2024: 8 of 45 companies on the "Worse" side.

21 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 89 companies compared. The sentences above are computed from all 89.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「Performance-based compensation is linked to performance indicators to raise awareness of improving performance in each fiscal year and is paid monthly together with fixed compensation. The performance indicators are consolidated net sales and net income attributable to owners of the parent for the previous fiscal year. The Nomination and Compensation Committee prepares a proposal linking compensation to the evaluations prescribed by the committee and determining the ratio to fixed compensation based on each director's position and responsibilities, and submits it to the Board of Directors.」

    From July 2025, the company introduced performance-based compensation linked to consolidated net sales and profit attributable to owners of the parent for the previous fiscal year, in addition to fixed compensation.
  2. FY2024AdvancedAnnual report

    「During the current fiscal year, the company held the Nomination and Compensation Committee twice. Attendance by each committee member was as follows.」

    The company disclosed that the Nomination and Compensation Committee met 2 times during the fiscal year to deliberate on the selection of representative directors and other officers, director compensation and candidates for election at the Annual General Meeting of Shareholders.
  3. FY2022AdvancedAnnual report

    「To ensure the appropriateness of compensation levels and transparency in performance evaluations, the Nomination and Compensation Committee, a majority of whose members are outside directors, prepares a draft of the compensation for directors other than directors who are Audit and Supervisory Committee members, taking comprehensive account of their positions, responsibilities, years in office, compensation levels at other companies, the company's performance and employee salary levels, and submits it to the Board of Directors.」

    The company disclosed the process under which the Nomination and Compensation Committee prepares a draft compensation proposal and submits it to the Board of Directors, together with specific details of the system, including compensation limits.
  4. FY2021First statedAnnual report

    「To establish a compensation structure that functions effectively as an incentive for the sustained enhancement of corporate value, the company referred a draft policy for determining the details of individual director compensation and other remuneration to the Nomination and Compensation Committee. Based on the committee's recommendations, the Board of Directors adopted the policy at its meeting held on 26 February 2021.」

    The company established a policy for determining director compensation based on the Nomination and Compensation Committee's deliberations and recommendations, and also set the maximum amount of director compensation.
Moved together

"Improving Convenience Through ICT" moved the same way as this thread, in the same document, in 3 of its 4 moves.

332222★123456
  1. ★This thread
  2. 1Improving Convenience Through ICT3×
  3. 2Entry into the pharmaceutical manufacturing and marketing business and making 藤永製薬 a subsidiary3×
  4. 3Business Expansion through M&A2×
  5. 4Track Record of Expanding the Health Insurance Pharmacy Network2×
  6. 5Insurance Pharmacy Store Base2×
  7. 6Revenue and Profit Growth2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Qol Holdings's next results are scheduled for 2026-11-05. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.